Alice S. Mims, MD

Articles by Alice S. Mims, MD

Dr. Mims on the Beat AML Master Trial in AML

ByAlice S. Mims, MD

May 26th 2020

Alice S. Mims, MD, discusses the Beat AML Master Trial in acute myeloid leukemia (AML).

Dr. Mims on Waiting for Molecular Tests Before Starting Therapy in AML

ByAlice S. Mims, MD

February 5th 2020

Alice S. Mims, MD, discusses her recommendations regarding holding therapy until molecular test results are received for symptomatic patients with acute myeloid leukemia.

Dr. Mims on the Emergence of Targeted Therapy in AML

ByAlice S. Mims, MD

January 21st 2020

Alice S. Mims, MD, discusses the emergence of targeted therapy in acute myeloid leukemia treatment.

Dr. Mims on Developed Mutations in AML

ByAlice S. Mims, MD

January 14th 2020

Alice S. Mims, MD, discusses developed resistance in acute myeloid leukemia.

Dr. Mims on Performing Molecular Profiling at Diagnosis in AML

ByAlice S. Mims, MD

January 8th 2020

Alice S. Mims, MD, discusses up front molecular profiling in patients with newly diagnosed acute myeloid leukemia.

Dr. Mims Discusses Momelotinib in Myelofibrosis

ByAlice S. Mims, MD

November 10th 2017

Alice S. Mims, MD, assistant professor of medicine, The Ohio State University Comprehensive Cancer Center, discusses momelotinib in patients with myelofibrosis.

Dr. Mims on the Current Challenges With Myelofibrosis

ByAlice S. Mims, MD

October 26th 2017

Alice S. Mims, MD, assistant professor of medicine, Ohio State University Comprehensive Cancer Center, discusses the current challenges with myelofibrosis.